Literature DB >> 9216716

Translocation (8;12;21)(q22.1;q24.1;q22.1): a new masked type of t(8;21)(q22;q22) in a patient with acute myeloid leukemia.

K Saitoh1, I Miura, A Ohshima, N Takahashi, M Kume, S Utsumi, Y Kobayashi, K Hashimoto, Y Hatano, T Nimura, M Saito, K Enomoto, M Ohhira, K Shimizu, M Ohki, A B Miura.   

Abstract

The translocation t(8;21)(q22;q22) is found in 40% of cases of acute myeloid leukemia (AML) designated as the subtype M2 in the French-American-British (FAB) classification. The 8;21 translocation is clinically of interest because patients with this subtype have a good prognosis. We describe a masked type of the translocation, t(8;12;21)(q22.1;q24.1;q22.1). The translocation was first interpreted as t(8;12)(q22;q24) based on cytogenetics, but was reevaluated as a result of Southern blot and fluorescence in situ hybridization (FISH) analyses.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9216716     DOI: 10.1016/s0165-4608(96)00320-2

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  2 in total

1.  Acute myeloid leukemia (FAB-M2) with a masked type of t(8;21) translocation revealed by spectral karyotyping.

Authors:  Jun-ichi Miyagi; Naoki Kakazu; Masato Masuda; Takashi Miyagi; Tamiko Toyohama; Tetsuro Nakazato; Takeaki Tomoyose; Tetsuharu Shinjyo; Akitoshi Nagasaki; Naoya Taira; Misao Ohki; Tatsuo Abe; Nobuyuki Takasu
Journal:  Int J Hematol       Date:  2002-11       Impact factor: 2.490

2.  A 29-gene signature associated with NOX2 discriminates acute myeloid leukemia prognosis and survival.

Authors:  Carla Ijurko; Nerea González-García; Purificación Galindo-Villardón; Ángel Hernández-Hernández
Journal:  Am J Hematol       Date:  2022-02-08       Impact factor: 13.265

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.